December 9, 2010
Your Brain : How It Learns New Stuff!
(Ivanhoe Newswire) -- Medical researchers have found a so-called "missing link" that explains the interaction between brain state and the neural triggers responsible for learning.
The good news : this may potentially opening up new ways of boosting cognitive function in the face of diseases such as Alzheimer's as well as enhancing memory in healthy people.
Describing their findings in the journal Neuron, researchers from Bristol's School of Physiology and Pharmacology have shown that acetylcholine facilitates NMDA receptors by inhibiting the activity of other proteins called SK channels whose normal role is to restrict the activity of NMDA receptors.
This discovery of a role for SK channels provides new insight into the mechanisms underlying learning and memory. SK channels normally act as a barrier to NMDA receptor function, inhibiting changes in the strength of connections between nerve cells and therefore restricting the brain's ability to encode memories. Findings from this latest research show that the SK channel barrier can be removed by the release of acetylcholine in the brain in order to enhance our ability to learn and remember information.
"These findings are not going to revolutionise the treatment of Alzheimer's disease or other forms of cognitive impairment overnight. However, national and international funding bodies have recently made research into aging and dementia a top priority so we expect many more advances in our understanding of the mechanisms underlying learning and memory in both health and disease," lead researcher Dr. Jack Mellor from the University of Bristol's Medical School was quoted as saying.
The team studied the effects of drugs that target acetylcholine receptors and SK channels on the strength of connections between nerve cells in animal brain tissue. They found that changes in connection strength were facilitated by the presence of drugs that activate acetylcholine receptors or block SK channels revealing the link between the two proteins.
"This could potentially be beneficial for patients suffering from Alzheimer's disease or schizophrenia," Dr. Mellor was quoted as saying.
SOURCE: Neuron; December 2010